A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide

SIMPLE SUMMARY: Glioblastoma (GB) is the most common primary malignant brain tumor in adulthood. The median survival of patients is approximately 15 months after the standard therapy including safe maximal resection followed by radiotherapy plus concomitant and adjuvant temozolomide. However, the su...

Descripción completa

Detalles Bibliográficos
Autores principales: Clavreul, Anne, Lemée, Jean-Michel, Soulard, Gwénaëlle, Rousseau, Audrey, Menei, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616081/
https://www.ncbi.nlm.nih.gov/pubmed/34830935
http://dx.doi.org/10.3390/cancers13225778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616081/
https://www.ncbi.nlm.nih.gov/pubmed/34830935
http://dx.doi.org/10.3390/cancers13225778

Ejemplares similares